KHIDI Competitors

Since its opening in 1994, Samsung Medical Center (SMC) has been one of Korea’s leading hospitals for complex, high-acuity cases. What sets us apart isn’t just our advanced medical technology – it’s how we use it. With precision diagnostics, patient-centered approach, and deeply coordinated care, we bring cutting-edge medicine to each patient, one case at a time.

CEO's Message Since 1962 as part of the Korea’s first 5-year Economic Plan, KOTRA has been dedicated to creating new export markets and increasing Korea’s trade value, which reached $1 trillion in 2011. In the late 1990s, the agency helped Korea overcome the Financial Crisis by starting its foreign direct investment promotion division. And in the last half century, KOTRA has played a significant role in supporting Korean companies expanding overseas. Today, the world economy is more volatile than ever due to the European financial crisis, China's hindered economic growth, upcoming elections in 15 countries and security issues in the Middle East. In preparation for a rapidly changing market environment, and using Korea’s expansive FTA network, KOTRA is focusing on the globalization of SMEs, the backbone of the Korean economy, by providing them with customized support related to global business establishment and export. To further expand Korea’s trade sector, KOTRA is increasing the exports of new growth industries such as the knowledge service industry, medical-bio industry and green industry. The culture-based Korean Wave is making economic waves as well with its high export value. By supporting these and other industries, KOTRA contributes to the economic development of Korea and developing countries through technological innovation, industrial infrastructure formation and HR development. We invite you to be a part of our journey of growth.

Daewoong Pharmaceuticals Co., Ltd pursues meaningful work by collaborating with great people, working with autonomy, and choosing opportunities that create shared value for the company, customers, and society. Above all, we are committed to driving real change and innovation through what we do. Establish in 1945, Daewoong Pharmaceuticals is a leading healthcare company in Korea that has achieved consecutive successes in new drug development through constant challenge and innovation. Today, we continue to expand a diverse pipeline and next-generation platform technologies, aiming to develop first-in-class and best-in-class innovative medicines for patients worldwide. Our commitment to global standards is proven by GMP certifications from major regulatory authorities such as the U.S. FDA and EMA, along with ISO certifications that demonstrate our excellence in quality, environmental management, and occupational health and safety systems. At Daewoong, we believe that the growth of our employees fuels the growth of the company. We foster a forward-looking corporate culture by promoting smart work practices, career development, and global talent training programs. Beyond Korea, we strive to become a global healthcare leader by creating new value for healthier lives and better quality of life worldwide.